Explanation:
Educational objective: Primary biliary cholangitis (previously termed primary biliary cirrhosis) is a chronic liver disease characterized by intrahepatic cholestasis due to autoimmune destruction of small bile ducts. It presents in middle-aged women with fatigue, pruritus, hepatomegaly, and elevated alkaline phosphatase. The diagnosis is confirmed with serum anti-mitochondrial antibody titers.
Choice B and E. Autoimmune hepatitis is associated with elevated titers of antinuclear antibodies and anti-smooth muscle antibodies. It is characterized by fluctuating hepatocellular injury (ie, elevated transaminases) rather than cholestasis. First-line treatment includes oral glucocorticoids.
Choice C. A number of medications can cause intrahepatic cholestasis, including certain antibiotics (eg, macrolides), anabolic steroids, and oral contraceptives. Levothyroxine is not associated with cholestasis.
Choice D. Abdominal MRI is primarily used to evaluate abdominal masses or clarify nonspecific abnormalities on other imaging tests. It is not needed in the evaluation of PBC.
Choice B and E. Autoimmune hepatitis is associated with elevated titers of antinuclear antibodies and anti-smooth muscle antibodies. It is characterized by fluctuating hepatocellular injury (ie, elevated transaminases) rather than cholestasis. First-line treatment includes oral glucocorticoids.